Case Report

Accepted on 08 May 2024

Difficult Diagnosis of Mycobacterium Tuberculosis Infection in Patients after Allogeneic Hematopoietic Stem Cell Transplantation: Two Case Reports and Literature Review

in Hematologic Malignancies

Zhenghua Liu
Dali Cai
Nan Su

Frontiers in Oncology

doi 10.3389/fonc.2024.1283320

Brief Research Report

Published on 08 May 2024

Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study

in Hematologic Malignancies

Bruna Murbach
Gislaine Duarte
Leonardo Carvalho Palma
Eliana Miranda
Guilherme Duffles
Graziele Pavan Furlin
Isabella Toni
Carmino De Souza
Larissa Binelli
Vitor Leonardo Bassan

Frontiers in Oncology

doi 10.3389/fonc.2024.1393191

341 views

Mini Review

Accepted on 07 May 2024

Frontiers in Oncology -Short Review Understanding Iron Homeostasis in MDS: The role of Erythroferrone

in Hematologic Malignancies

Mohammed Abba
Vladimir Ryabov
Daniel Nowak
Wolf-Karsten Hofmann
Tobias Boch

Frontiers in Oncology

doi 10.3389/fonc.2024.1404817

Case Report

Accepted on 07 May 2024

Spinal myeloid sarcoma presenting as initial symptom in acute promyelocytic leukemia with a rare cryptic PLZF::RARα fusion gene: a case report and literature review

in Hematologic Malignancies

Xuejiao Zhang
Tao Wang
Pu Chen
Yan Chen
Zhimei Wang
Tianhong Xu
Pengfei Yu
Peng Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1375737

Mini Review

Accepted on 07 May 2024

Mechanisms and Management of CAR T Toxicity

in Hematologic Malignancies

Christopher James Ferreri
Manisha Bhutani

Frontiers in Oncology

doi 10.3389/fonc.2024.1396490

Case Report

Published on 03 May 2024

Case report: ‘Atypical Richter transformation from CLL-type monoclonal B-cell lymphocytosis into Burkitt lymphoma in a treatment naïve patient’

in Hematologic Malignancies

Annaïse J. Jauch
Ilaria Alborelli
Andreas Reusser
Albert Baschong
Cyrill Rütsche
Olivier Bignucolo
Jakob Passweg
Stefan Dirnhofer
Fatime Krasniqi

Frontiers in Oncology

doi 10.3389/fonc.2024.1296238

233 views

Editorial

Published on 02 May 2024

Editorial: Reviews in hematologic malignancies: 2023

in Hematologic Malignancies

Billy Michael Chelliah Jebaraj
Michael Liew
Felix Seyfried

Frontiers in Oncology

doi 10.3389/fonc.2024.1412843

152 views

Original Research

Published on 02 May 2024

Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia

in Hematologic Malignancies

Claudia Núñez-Torrón Stock
Carlos Jiménez Chillón
Fernando Martín Moro
Juan Marquet Palomanes
Miguel Piris Villaespesa
Ernesto Roldán Santiago
Eulalia Rodríguez Martín
Anabelle Chinea Rodríguez
Valentín García Gutiérrez
Gemma Moreno Jiménez

Frontiers in Oncology

doi 10.3389/fonc.2024.1394648

147 views

Case Report

Published on 02 May 2024

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report

in Hematologic Malignancies

Elisa Diral
Gloria Catalano
Maria Vittoria Cicinelli
Andrea Distefano
Sara Mastaglio
Luca Vago
Maria Teresa Lupo Stanghellini
Massimo Bernardi
Maurilio Ponzoni
Fabio Ciceri

Frontiers in Oncology

doi 10.3389/fonc.2024.1399894

158 views

Case Report

Published on 01 May 2024

Osteolytic lesions as a presenting sign of acute myeloid leukemia: a case report

in Hematologic Malignancies

Jingqian Zhang
Shidai Mu
Li Cai
Lisha Ai
Yaohui Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1364266

266 views

Brief Research Report

Accepted on 30 Apr 2024

Efficacy and Safety of Once Weekly Selinexor 40 mg Versus 60 mg with Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

in Hematologic Malignancies

Darrell White
Gary Schiller
Sumit Madan
Suzanne Lentzsch
Evgeni Chubar
Noa Lavi
Dane R Van Domelen
Ohad Bentur
Muhamed Baljevic

Frontiers in Oncology

doi 10.3389/fonc.2024.1352281

Original Research

Accepted on 29 Apr 2024

A Hybrid Protocol CLAG-M, a possible player for the first-line therapy of Patients with Mixed Phenotype Acute Leukemia. A Polish Adult Leukemia Group experience

in Hematologic Malignancies

Magdalena Karasek
Anna Armatys
Marek Skarupski
Lukasz Bolkun
Katarzyna Budziszewska
Joanna Drozd-Sokołowska
Ewa Zarzycka
Patrycja Mensah-Glanowska
Małgorzata Gajewska
Janusz Hałka

Frontiers in Oncology

doi 10.3389/fonc.2024.1395992

Case Report

Accepted on 29 Apr 2024

Case report: Lymph node metastasis of pelvicalveolar rhabdomyosarcoma diagnosed by fine needle aspiration cytology

in Hematologic Malignancies

Xinyu Hu
Chenxin Huang
Qiyuan Li
Baolin Wu
Chuyun Yue
Xueying Su

Frontiers in Oncology

doi 10.3389/fonc.2024.1340865

Review

Accepted on 29 Apr 2024

The Treatment of Follicular Lymphoma with CD-19 Directed Chimeric Antigen Receptor-T Cell Therapy

in Hematologic Malignancies

Ryan Jacobs
Caron Jacobson

Frontiers in Oncology

doi 10.3389/fonc.2024.1384600

Original Research

Accepted on 29 Apr 2024

Activated interferon response from DNA damage in multiple myeloma cells contributes to the chemotherapeutic effects of anthracyclines

in Hematologic Malignancies

Jin Li
Zhuxia Jia
Rongxuan Wang
Bitao Xiao
Yanan Cai
Tianshu Zhu
Weiya Wang
Xinyue Zhang
Shu Fan
Xiaolong Fan

Frontiers in Oncology

doi 10.3389/fonc.2024.1357996

Original Research

Accepted on 26 Apr 2024

No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine -a prospective multicenter study by Polish Adult Leukemia Group

in Hematologic Malignancies

Krzysztof Mądry
Karol Lis
Elżbieta Sienkiewicz
Joanna Drozd-Sokołowska
Przemyslaw Biecek
Oktawia Sośnia
Aleksandra Gołos
Magdalena Olszewska-Szopa
Agata Obara
Zuzanna Walkowiak

Frontiers in Oncology

doi 10.3389/fonc.2024.1404322

Navigation group

Articles

Difficult Diagnosis of Mycobacterium Tuberculosis Infection in Patients after Allogeneic Hematopoietic Stem Cell Transplantation: Two Case Reports and Literature Review

Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study

Frontiers in Oncology -Short Review Understanding Iron Homeostasis in MDS: The role of Erythroferrone

Spinal myeloid sarcoma presenting as initial symptom in acute promyelocytic leukemia with a rare cryptic PLZF::RARα fusion gene: a case report and literature review

Mechanisms and Management of CAR T Toxicity

Case report: ‘Atypical Richter transformation from CLL-type monoclonal B-cell lymphocytosis into Burkitt lymphoma in a treatment naïve patient’

Editorial: Reviews in hematologic malignancies: 2023

Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report

Osteolytic lesions as a presenting sign of acute myeloid leukemia: a case report

Efficacy and Safety of Once Weekly Selinexor 40 mg Versus 60 mg with Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

A Hybrid Protocol CLAG-M, a possible player for the first-line therapy of Patients with Mixed Phenotype Acute Leukemia. A Polish Adult Leukemia Group experience

Case report: Lymph node metastasis of pelvicalveolar rhabdomyosarcoma diagnosed by fine needle aspiration cytology

The Treatment of Follicular Lymphoma with CD-19 Directed Chimeric Antigen Receptor-T Cell Therapy

Activated interferon response from DNA damage in multiple myeloma cells contributes to the chemotherapeutic effects of anthracyclines

No advantage of antimicrobial prophylaxis in AML/MDS/CMML patients treated with azacitidine -a prospective multicenter study by Polish Adult Leukemia Group